Office of the Director, National Institutes of Health; Notice of Meeting, 9541 [07-961]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices
pwalker on PROD1PC71 with NOTICES
Biological Materials Availability:
Biological materials related to this
technology are not available at this time.
Licensing Availability: This
application is available for license on a
non-exclusive or exclusive basis.
Licensing Contact: Susan S. Rucker;
301/435–4478; e-mail:
ruckersu@mail.nih.gov.
Dated: February 22, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–3695 Filed 3–1–07; 8:45 am]
Genes Expressed in Prostate Cancer
and Methods of Use
Description of Technology: This
invention is a novel gene, called New
Gene Expressed in Prostate (NGEP).
This gene appears to be expressed only
in human prostate and prostate cancer.
This gene has two known splice variants
of significantly different size. The
shorter splice variant encodes a
cytoplasmic protein, while the longer
splice variant encodes a plasma
membrane protein, which has been
detected on the plasma membrane of
human cancer cells.
This patent application contains
claims to the polypeptide, NGEP,
nucleotides encoding NGEP, antibodies
that bind NGEP polypeptides, and
methods of using these polypeptides,
polynucleotides, and antibodies.
The presence of the protein on the
cell surface and the selective expression
in prostate and prostate cancer make
this a potential target for prostate cancer
diagnostics and therapeutics. Potential
therapeutics could be gene-based,
vaccines, antibodies, or
immunoconjugates.
Inventors: Ira Pastan, Tapan Bera, and
Byungkook Lee (NCI.)
Publications:
1. S Das et al. NGEP, a prostatespecific plasma membrane protein that
promotes the association of LNCaP cells.
Cancer Res. 2007 Feb 15; 67(4):1594–
1601.
2. TK Bera et al. NGEP, a gene
encoding a membrane protein detected
only in prostate cancer and normal
prostate. Proc Natl Acad Sci USA. 2004
Mar 2; 101(9):3050–3064.
Patent Status:
1. U.S. Provisional Application No.
60/461,399 filed 08 Apr 2003 (HHS
Reference No. E–148–2003/0–US–01).
2. PCT Application No. PCT/US04/
10588 filed 05 Apr 2004, which
published as WO 2004/092213 on 28
Oct 2004 (HHS Reference No. E–148–
2003/0–PCT–02).
3. U.S. Patent Application No. 10/
552,515 filed 06 Oct 2005 (HHS
Reference No. E–148–2003/0–US–03).
Licensing Status: Available for nonexclusive licensing.
Licensing Contact: Jesse S. Kindra,
J.D.; 301/435–5559;
kindraj@mail.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
18:44 Mar 01, 2007
Jkt 211001
BILLING CODE 4140–01–P
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Office of AIDS Research Advisory
Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: April 19, 2007.
Time: 9 a.m. to 5 p.m.
Agenda: The meeting will focus on HIVrelated Complications including
Malignancies, Cardiovascular Disease, and
Metabolic Complications. An update will be
provided on the OARAC Working Groups for
Treatment and Prevention Guidelines.
Place: National Institutes of Health, 5635
Fishers Lane, Rockville, MD 20852.
Contact Person: Christina Brackna,
Coordinator, Program Planning and Analysis,
Office of Aids Research, Office of the
Director, NIH, 5635 Fishers Lane MSC 9310,
Suite 4000, Rockville, MD 20852, (301) 402–
8655, cm53v@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s Center’s home page: https://
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
9541
www.ni.gov/od/oar/index.htm, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–961 Filed 3–1–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the twelfth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8 a.m. to approximately 5 p.m. on
Monday, March 26, 2007 and 8 a.m. to
approximately 5 p.m. on Tuesday,
March 27, 2007, at the Marriott Inn and
Conference Center, University of
Maryland—College Park, 3501
University Boulevard East, Adelphi, MD
20783. The meeting will be open to the
public with attendance limited to space
available. The meeting also will be Web
cast.
The agenda will focus on the
oversight of genetic testing, including
the role of the private sector in assuring
the quality and validity of genetic tests;
the impact of gene patents and licensing
practices on patient access to genetic
technologies, including a progress
report on the Committee’s study; and
the status of Federal genetic information
nondiscrimination legislation. The
Committee will be briefed on the
Secretary’s Personalized Health Care
Initiative and the work of the American
Health Information Community,
particularly its Personalized Health Care
Working Group. The Committee’s report
on the Policy Issues Associated with
Undertaking a New Large U.S.
Population Cohort Project on Genes,
Environment and Disease will be
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 72, Number 41 (Friday, March 2, 2007)]
[Notices]
[Page 9541]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-961]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: April 19, 2007.
Time: 9 a.m. to 5 p.m.
Agenda: The meeting will focus on HIV-related Complications
including Malignancies, Cardiovascular Disease, and Metabolic
Complications. An update will be provided on the OARAC Working
Groups for Treatment and Prevention Guidelines.
Place: National Institutes of Health, 5635 Fishers Lane,
Rockville, MD 20852.
Contact Person: Christina Brackna, Coordinator, Program Planning
and Analysis, Office of Aids Research, Office of the Director, NIH,
5635 Fishers Lane MSC 9310, Suite 4000, Rockville, MD 20852, (301)
402-8655, cm53v@nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's Center's home
page: https://www.ni.gov/od/oar/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 23, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-961 Filed 3-1-07; 8:45 am]
BILLING CODE 4140-01-M
